BCC Research Releases Report on Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Reportlinker.com announces that a new market research report is available in its catalogue: Nanoparticles in Biotechnology, Drug Development and Drug Delivery

This BCC Research report provides detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating various disease conditions in both men and women. The applicability of specific types of nanoparticles for specific applications is also discussed. CAGR projections are given from the period 2014 through 2019.

Use this report to:

• Receive a range of information, from detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating various disease conditions in both men and women.
• Receive information on specific classes of nanoparticles and the pharmaceutical products associated with them.
• Examine competitive environment with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.
• Learn about the major licensing, collaborative partnerships and, merger and acquisition activities in the industry.

Highlights

• The global market for nanoparticles in biotechnology and pharmaceuticals reached nearly $25.0 billion in 2013. This market is expected to reach $29.6 billion in 2014 and $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22.0% for the period of 2014 to 2019.
• Drug delivery systems as a segment is projected to increase from nearly $15.8 billion in 2014 to $44.5 billion by 2019, with a CAGR of 23.0% for the period of 2014 to 2019.
• Drug development and formulation as a segment is projected to increase from nearly $12.6 billion in 2014 to $32.3 billion by 2019, with a CAGR of 20.8% for the period of 2014 to 2019.